AARVIK THERAPEUTICS

Pharmaceutical products for the prevention and treatment cancer, infectious and neurologic diseases and disorders; pharmaceutical preparations for the diagnosis and treatment of cancer, infectious and neurologic diseases and disorders; Pharmaceutical preparations, substances and compositions, namely, medical diagnostic reagents in the nature of mono-specific antibodies, bi-specific, and multi-specific antibodies, antibody-drug conjugates, T cell, NK cell, and Macrophage engaging antibodies, all for use in oncology, neurology and infectious disease diagnostics and treatment

Scientific research for medical purposes in the field of cancer, infectious and neurologic diseases and disorders; research and development services in the field of antibodies; Scientific and technological services and research relating thereto, namely, scientific research, analysis and testing in the fields of mono-specific antibodies, bi-specific, multi-specific antibodies; antibody-drug conjugates, T cell, NK cell, and Macrophage engaging antibodies; Antibody engineering; Custom design and engineering of antibodies; Research and development of pharmaceuticals for the treatment of cancer, infectious and neurologic diseases and disorders; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Research development and establishment of testing specifications and procedures in the field of cancer research, and scientific research in the field of cancer diagnosis and treatment; Providing scientific research information in the field of cancer research, and providing scientific research information in the field of cancer diagnosis and treatment